Orix (IX) EBIT Margin Growth (1y) (2010 - 2026)
Powered by 
Analysis
Orix (IX) EBIT Margin Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Orix | 43.64 Bn | 43.64 Bn | 4.68 Bn | -78.00 |
| 2 | Royalty Pharma | 26.15 Bn | 25.32 Bn | - | -1,651.00 |
| 3 | Royal Gold | 21.54 Bn | 21.36 Bn | 390.45 Mn | -552.00 |
| 4 | OR Royalties | 6.72 Bn | 6.64 Bn | 82.22 Mn | 837.00 |
| 5 | Encore Capital | 2.11 Bn | 1.93 Bn | 455.04 Mn | 391.00 |
| 6 | Atlanticus Holdings | 1.41 Bn | 857.38 Mn | 686.46 Mn | 55.00 |
| 7 | Jefferson Capital | 1.18 Bn | 1.15 Bn | - | -1,087.00 |
| 8 | Upbound | 1.06 Bn | 953.54 Mn | 594.84 Mn | 28.00 |
| 9 | Lufax Holding | 1.05 Bn | -1.58 Bn | - | -1,647.00 |
| 10 | Burford Capital | 962.26 Mn | 962.26 Mn | - | -1,721.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -78.00 |
| Mar 31, 2026 | 405.00 |
| Dec 31, 2025 | -1,438.00 |
| Sep 30, 2025 | 1,114.00 |
| Jun 30, 2025 | 387.00 |
| Mar 31, 2025 | -5,484.00 |
| Dec 31, 2024 | 1,481.00 |
| Sep 30, 2024 | -793.00 |
| Jun 30, 2024 | -8.00 |
| Mar 31, 2024 | 1,245.00 |
| Dec 31, 2023 | 6.00 |
| Sep 30, 2023 | 235.00 |
| Jun 30, 2023 | -48.00 |
| Mar 31, 2023 | 4,641.00 |
| Dec 31, 2022 | 244.00 |
| Sep 30, 2022 | -741.00 |
| Jun 30, 2022 | -400.00 |
| Mar 31, 2022 | -870.00 |
| Dec 31, 2021 | -103.00 |
| Sep 30, 2021 | 332.00 |